Date: November 4, 2026

KMP / Board / Auditor Changes

Not Specified

Dividend Declaration or Non-Declaration

Not Specified

Board Meeting Outcomes

Not Specified

Financial Results

Not Specified

Disinvestment / Strategic Actions

Not Specified

Other Operational / Legal / Strategic Disclosures

ESOP Grant Details

  • The Nomination and Remuneration Committee approved the grant of 37,019 stock options under the Bluspring Enterprises Limited Employee Stock Option Scheme, 2026 (ESOS 2026) on November 4, 2026.
  • The grant was made in accordance with the terms of the scheme and applicable provisions of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
  • Total number of shares covered: 37,019 equity shares of face value INR 10 each.
  • Exercise price: INR 10 per share.
  • Vesting period: Minimum 1 year, maximum 4 years from the date of grant.
  • Exercise period: Maximum 3 years from the date of each vesting.
  • Equity shares under ESOS 2026 will be sourced from Primary Issuance and/or Secondary Acquisition route through the Bluspring ESOP Trust.
  • The scheme includes provisions for handling stock options in cases of death, permanent incapacity, resignation, termination, retirement, etc.
  • Fair and reasonable adjustments to the number of Options and Exercise Price will be made for corporate actions such as rights issues, bonus issues, merger, sale of division.
  • Equity shares arising from exercise of Vested Options will not be subject to any lock-in from the date of transfer.